Multi-Agent Portfolio

Digest de scouts: X/opportunity scanner + top holdings 13F + news. Lo consume el consejo (Sentiment/Quant/Fundamental → Risk → PM) en el postmarket.

# MAP Sources Digest — 2026-08-28

_Generated 2026-08-28T20:16:09.022087+00:00_

## 1) Opportunity / X scanner

- Scan: `2026-08-27` · ideas=0 · rejected=24
- Ninguna idea pasó el filtro hoy (mirar rejected top).

### X discourse — top rejected (still useful signal)
- **SMMT** (0.7% 1d / 15.29% 5d) — Según el discurso en X, Summit encadenó su 5to Ph3 positivo (HARMONi-GI1 en biliary tract) con compra insider de ~$100M y PDUFA de NSCLC en noviembre; tesis con catalizador fresco y track record.
  - catalysts: Ph3 HARMONi-GI1 positivo: ivonescimab+chemo venció a durvalumab+chemo en OS en BTC (1er Ph3 en biliary tract en ganar OS vs anti-PD-(L)1), PDUFA ivonescimab NSCLC 14-nov-2026 (ya aprobado en China), Insider buying fuerte: Duggan + co-CEO ~$100M a ~$13.12
  - rejected: final_score_below_0.55
  - risks: Binario FDA en 3 meses; valuación ya descontó varios wins; concentración en un solo asset.
- **ANF** (-1.35% 1d / 38.78% 5d) — Según el discurso en X, Abercrombie rompió con un Q2 fuerte + guía subida, pero el escepticismo nota que gran parte del beat es por refund de aranceles y recompras, no ventas core.
  - catalysts: Q2 EPS $4.17 (beat) + guía FY subida; 15to trimestre consecutivo de crecimiento de top line, ~$100M de beneficio por refund de aranceles, Volumen 24x el promedio, reacción explosiva
  - rejected: extended_chase (dist_ma20=29.01%, day=-1.35%)
  - risks: Calidad del beat cuestionada; retail sensible a consumo; comps planas a nivel compañía.
- **SMTC** (1.16% 1d / 14.05% 5d) — Según el discurso en X, Semtech imprimió un Q2 con beat y guía fuerte por la ola AI/óptica con backlog visible; el debate es si 47x P/E forward ya lo paga.
  - catalysts: Q2: beat en rev y EPS + guía Q3 fuerte (AI datacenter/óptica), Backlog FY2027 'all booked', FY2028 >70% visibilidad, GM ~54.5%, FCF positivo, contenido por transceiver creciendo
  - rejected: final_score_below_0.55
  - risks: Valuación exigente; semis cíclicos; China mix; tope del rango de mcap.
- **TENB** (11.76% 1d / 10.29% 5d) — Según el discurso en X, Tenable entra al S&P SmallCap 600 el 31-ago (filtrado con index fade) y sumó FedRAMP con speculación de compra; el index move estaba ampliamente anticipado.
  - catalysts: Suma al S&P SmallCap 600 (efectivo 31-ago, reemplaza a LEG), Aprobación FedRAMP (milestone para contracting federal), Speculación M&A/takeover post-aprobación (Altucher)
  - rejected: final_score_below_0.55
  - risks: Index addition ya priceada (leaked); fade post-inclusión; spec M&A sin deal confirmado.
- **CELC** (-1.94% 1d / 2.95% 5d) — Según el discurso en X, Celcuity presentó el sNDA el 26-ago para expandir la label de su aprobado a la población PIK3CA-mutant, con Ph3 claramente positivo.
  - catalysts: sNDA presentada a FDA el 26-ago para REVTORPYK (gedatolisib) en HR+/HER2- PIK3CA-mutant breast cancer (label expansion), Ph3: PFS 11.1 vs 5.6 meses vs comparador, Ya aprobado en wild-type; expansión del mercado direccionable
  - rejected: volume_ratio_below_0.8 (0.42)
  - risks: sNDA = revisión de meses; dependencia de un solo producto; biotech volátil.
- **ZYME** (-1.01% 1d / 9.18% 5d) — Según el discurso en X, la aprobación de zanidatamab en 1L (label amplia) ya está confirmada y Zymeworks cobra el milestone de Jazz; carry-forward con catalizador resuelto.
  - catalysts: FDA aprobó zanidatamab (Ziihera) 1L HER2+ GEA el 25-ago, label amplia sin restricción PD-L1, Milestone $250M de Jazz + hasta $1.3B en pagos y royalties 10-20%, HC Wainwright subió PT a $55
  - rejected: final_score_below_0.55
  - risks: Sell-the-news post-aprobación; valor comercial mayormente licenciado a Jazz; perfil GI.
- **OUST** (1.87% 1d / -3.72% 5d) — Según el discurso en X, Ouster crece 56% con márgenes y caja, pero el discurso mezcla tesis real con promoción coordinada de PTs agresivos.
  - catalysts: Revenue trimestral ~$55M (+56% YoY) con GM 49%, Caja neta ~$245M, sin raise dilutivo, PTs ~$40 con opciones mostrando resistencia $40-50
  - rejected: volume_ratio_below_0.8 (0.63)
  - risks: Story a largo plazo con mucho hype retail; lidar aún no probado a escala robotaxi; +31% reciente = chase.
- **DKS** (1.63% 1d / -26.53% 5d) — Según el discurso en X, Dick's se derrumbó ~30% por la guía arrastrada por Foot Locker; el debate es si es oportunidad o señal de consumo débil.
  - catalysts: -30% en un día post-earnings por Foot Locker (comps -3.6%) arrastrando guía FY, Comps core Dick's +4.9% sólidas, Debate dip-buy vs debilidad consumidor 15-25
  - rejected: structure_breakdown
  - risks: Breakdown técnico severo; la integración de Foot Locker sigue siendo un problema.

## 2) 13F top holdings (latest filing on disk)

### Berkshire — filing 2026-08-14 · 29 names
- APPLE INC: $65.95B (22.04%)
- AMERICAN EXPRESS CO: $51.282B (17.14%)
- COCA COLA CO: $32.508B (10.86%)
- ALPHABET INC: $28.158B (9.41%)
- BANK OF AMER CORP: $27.544B (9.2%)
- CHEVRON CORPORATION: $13.986B (4.67%)
- OCCIDENTAL PETE CORP: $12.868B (4.3%)
- CHUBB LIMITED: $11.67B (3.9%)

### Pershing Square — filing 2026-05-15 · 11 names
- BROOKFIELD CORP: $2.416B (17.62%)
- AMAZON COM INC: $2.385B (17.39%)
- UBER TECHNOLOGIES INC: $2.155B (15.71%)
- MICROSOFT CORP: $2.093B (15.26%)
- RESTAURANT BRANDS INTL INC: $1.674B (12.2%)
- META PLATFORMS INC: $1.522B (11.1%)
- HOWARD HUGHES HOLDINGS INC: $1.193B (8.7%)
- SEAPORT ENTMT GROUP INC: $0.108B (0.79%)

### Scion/Burry — filing 2025-11-03 · 8 names
- PALANTIR TECHNOLOGIES INC: $0.912B (66.04%)
- NVIDIA CORPORATION: $0.187B (13.51%)
- PFIZER INC: $0.153B (11.07%)
- HALLIBURTON CO: $0.061B (4.45%)
- MOLINA HEALTHCARE INC: $0.024B (1.73%)
- LULULEMON ATHLETICA INC: $0.018B (1.29%)
- SLM CORP: $0.013B (0.96%)
- BRUKER CORP: $0.013B (0.95%)

### Appaloosa — filing 2026-08-14 · 27 names
- AMAZON COM INC: $1.192B (15.43%)
- MICRON TECHNOLOGY INC: $1.125B (14.57%)
- TAIWAN SEMICONDUCTOR MANUFAC: $0.788B (10.2%)
- ALPHABET INC: $0.654B (8.46%)
- UBER TECHNOLOGIES INC: $0.555B (7.19%)
- ISHARES INC: $0.49B (6.34%)
- META PLATFORMS INC: $0.38B (4.92%)
- VISTRA CORP: $0.351B (4.55%)

### ARK — filing 2026-08-14 · 191 names
- Tesla Inc: $1.161B (7.54%)
- Advanced Micro Devices Inc: $0.823B (5.34%)
- Space Exploration Technologies Corp: $0.765B (4.97%)
- Tempus AI Inc: $0.581B (3.77%)
- Robinhood Markets Inc: $0.525B (3.41%)
- CRISPR Therapeutics AG: $0.516B (3.35%)
- Shopify Inc: $0.475B (3.08%)
- Twist Bioscience Corp: $0.468B (3.04%)

### Tiger Global — filing 2026-08-14 · 46 names
- TAIWAN SEMICONDUCTOR MANUFAC: $2.331B (9.72%)
- AMAZON COM INC: $2.308B (9.62%)
- NVIDIA CORPORATION: $2.241B (9.34%)
- ALPHABET INC: $2.075B (8.65%)
- META PLATFORMS INC: $1.59B (6.63%)
- LAM RESEARCH CORP: $1.371B (5.72%)
- SEA LTD: $1.204B (5.02%)
- APPLIED MATLS INC: $1.18B (4.92%)

## 3) News (yfinance / map_research)

- SPY $769.35 · 5d 0.77% (H 775.29 / L 762.08)

### MSFT
- Anthropic’s $45B Nscale Deal Adds an Eighth Compute Corridor — and a Pattern of Betting on Startups (Forkast News, 2026-08-28)
- Sector Update: Tech Stocks Fall Late Afternoon (MT Newswires, 2026-08-28)
- Microsoft Just Gained 14% in a Month: Take Profits, or Buy More? (24/7 Wall St., 2026-08-28)

### GOOGL
- Trending: Take-Two Interactive price ascends as 'Grand Theft Auto VI' is teased (Yahoo Finance Video, 2026-08-28)
- Is AI's 'capex tsunami' the catalyst for the next big credit boom? (Yahoo Finance Video, 2026-08-28)
- Sector Update: Tech Stocks Fall Late Afternoon (MT Newswires, 2026-08-28)

### AMZN
- Sector Update: Tech Stocks Fall Late Afternoon (MT Newswires, 2026-08-28)
- Marvell Technology Issues Soft Quarterly Gross Margin Outlook on Greater Custom Mix, B. Riley Says (MT Newswires, 2026-08-28)
- Microsoft Just Gained 14% in a Month: Take Profits, or Buy More? (24/7 Wall St., 2026-08-28)

### JPM
- JPMorgan (JPM) Hiring Bank of America (BAC)’s David Fishman to Lead Tech M&A (Insider Monkey, 2026-08-28)
- How Is JPMorgan Chase's Stock Performance Compared to Other Diversified Bank Stocks (Barchart, 2026-08-28)
- I'm 61 and have been laid off before I'm ready to retire - what can I do? (Moneywise, 2026-08-28)

### LLY
- Sector Update: Healthcare Stocks Decline Late Afternoon (MT Newswires, 2026-08-28)
- Is OmniAb (OABI)’s Eli Lilly (LLY) Partnership a Game Changer for OABI? (Insider Monkey, 2026-08-28)
- GLP-1 Coverage Fell From 72% to 60%. Is Eli Lilly’s Weight-Loss Boom Hitting an Insurance Wall? (24/7 Wall St., 2026-08-28)

### BRK-B
- Warren Buffett's No. 1 Rule That Beats 90% of Investors (MoneyLion, 2026-08-28)
- Berkshire Hathaway (BRK.A) Puts $6.8 Billion Behind Greg Abel’s Housing Bet (Simply Wall St., 2026-08-28)
- Sundar Pichai Raised Alphabet's 2026 Capex Forecast to as Much as $205 Billion, Sending the Stock Down 7%. Was That an Overreaction That Investors Should Buy Into? (Motley Fool, 2026-08-28)

### XOM
- Targa Resources (TRGP) vs. ExxonMobil (XOM): Which Stock Is the Better Energy Bet? (Insider Monkey, 2026-08-28)
- Oil Remains Above $80: Are Permian Stocks Well Poised to Gain? (Zacks, 2026-08-28)
- I'm Not Selling ExxonMobil, Even With Oil Prices Where They Are (Motley Fool, 2026-08-28)

### V
- PayPal Stock Dives as Stripe’s Takeover Bid Collapses. 2 Reasons It Can Bounce Back. (Barrons.com, 2026-08-28)
- Visa (V) Rebound Driven by Q2 Outperformance and Guidance Hike (Insider Monkey, 2026-08-28)
- Visa’s Korean Pivot: Building the Rails for an Agentic Future (Forkast News, 2026-08-28)

### ZYME
- Zymeworks (ZYME), What Is Behind The Renewed Attention? (Simply Wall St., 2026-08-28)
- Is Zymeworks (ZYME) Stock Fully Priced After Its 301% Run? (Simply Wall St., 2026-08-28)
- Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens (Benzinga, 2026-08-27)

### SPY
- Optics Stocks Slide as AI Hardware Trade Cools: Applied Optoelectronics and Lumentum Fall 6%, Coherent Drops 5% (24/7 Wall St., 2026-08-28)
- AppLovin Rises 4% After 54% YTD Slide: Does a Subdued P/E Make APP Stock a Good Value Here? (24/7 Wall St., 2026-08-28)
- Rivian Falls 6% as CFO Departs for GE Vernova; Lucid Slips, Tesla Holds Steady (24/7 Wall St., 2026-08-28)

## Cómo usar esto (Bull / Bear / PM)

- Bull: priorizá catalysts de la sección X + news alineados a momentum USA.
- Bear: usá reasons_rejected + risks + concentración 13F como veto/overcrowding.
- PM: no copies 13F ciegamente; es contexto, no orden.